![](/img/cover-not-exists.png)
LB6. EDP-938, a Novel RSV N-Inhibitor, Administered Once or Twice Daily Was Safe and Demonstrated Robust Antiviral and Clinical Efficacy in a Healthy Volunteer Challenge Study
Coakley, Eoin, Ahmad, Alaa, Larson, Kajal, McClure, Ty, Lin, Kai, Lin, Kai, Tenhoor, Kursten, Eze, Kingsley, Noulin, Nicolas, Horvathova, Veronika, Murray, Bryan, Baillet, Mark, Mori, Julie, Adda, NatVolume:
6
Language:
english
Journal:
Open Forum Infectious Diseases
DOI:
10.1093/ofid/ofz415.2489
Date:
October, 2019
File:
PDF, 895 KB
english, 2019